MEDICAL GRADE DEVICE
​
​FDA, ISO, CE, IEC, ARTG cleared. Exceptional clinical research, see studies below.

HIGHLY VERSATILE
​
​Can help with complex conditions, pain senditivity, sports injuries and more.

QUICK & CONVENIENT
​
Non invasive, easy to administer up to 30 minutes treatments.

MULTI FUNCTIONAL
​
​Pain relief (red laser) plus antimicrobial applications (violet laser).

Our Laser Device

Our Low Level Laser device is FDA 510(K) market cleared and entered in the TGA (ARTG 393431) for treating chronic / acute neck and shoulder pain, musculoskeletal pain, and acne vulgaris.
​
This dual-diode laser with red and violet wavelength allows the device to treat a wide variety of pain including: Orthopaedic pain – sprains, whiplash, muscular pain, cervical or lumbar radiculopathy, tendinitis, and carpal tunnel syndrome. The device has also shown positive effects on individuals with chronic conditions like arthritis and osteoarthritis, and in treating post-surgical pain; Neuropathic pain, including various types of neuralgia and diabetic neuropathy; Pain management for athletes recovering from training or injuries; Bacterial, fungal, or viral infections.

How does it work?

The Laser delivers parcels of light energy into the cell which the cell can use, and the parcels are delivered in the most effective and efficient way. This added energy fuels key processes, stimulating healing, relieving pain, reducing inflammation, and restoring function.
​
The Laser emits two true laser beams – a red laser promotes healing through its 635nm beam (7.5mW output), and a violet laser provides an antimicrobial effect through its 405nm beam (5mW output).

​Laser device  Specifications ​(download datasheet)

​Call 0402 904 828

The Science Behind EVRL® Laser

While the benefits of Low-Level Laser Therapy (LLLT) have been observed in hundreds of medical studies, the exact mechanisms that lead to these results are still being explored. Although we still have a lot to learn about the effects of light energy on different types of cells, the leading theory is that LLLT generates therapeutic effects through stimulating and enhancing specific biochemical processes within cells.

More specifically, utilising the first law in photochemistry (Grotthuss-Draper law), laser energy is transferred to cytochrome c oxidase (CcO) – a respiratory energy-transducing enzyme which is involved in the electron transport chain in mitochondria. This energy transfer causes photodissociation of inhibitory nitric oxide from CcO, leading to an enhancement of enzyme activity, electron transport, mitochondrial respiration, and adenosine triphosphate (ATP) production. Consequently, by altering the cellular redox state, LLLT induces the activation of numerous intracellular signalling pathways, and alters the affinity of transcription factors concerned with cell proliferation, survival, repair, and regeneration.

Our lasers utilise true laser technology, optimising photonic energy delivery through the use of monochromatic, collimated, and coherent beams of light. That is, the light emitted by a true laser is composed from photons that have the same wavelength (monochromatic), travel in the same direction / do not disperse (collimated), and are in phase in space and time (coherent). 
​
These lasers were specifically designed to deliver the optimal amount of energy required to stimulate and enhance cell function while not damaging cells or producing painful heat sensations – all of our non-thermal LLLT devices are classified as ‘Class II Lasers’ by the FDA in virtue of their low output and very low risk of hazard.

The Benefits of Low Level Laser Therapy

Clinical studies and trials of Laser Therapy technologies indicate the following beneficial effects of Low-Level Laser Therapy (LLLT).

Anti-Inflammation. LLLT creates an anti-edema effect by dilating blood vessels and activating the lymphatic drainage system (which drains swollen areas). This reduces swelling caused by trauma or inflammation.
​
Anti-Pain (Analgesic). LLLT exerts a very beneficial effect on pain in multiple ways: It partially blocks neural transmission of pain signals to the brain; It decreases nerve sensitivity; It lessens pain by reducing edema; It helps to increase the production of high levels of painkilling chemicals such as endorphins, enkephalins, and opioids from the brain and adrenal gland.

Accelerated Tissue Repair and Cell Growth. Photons of light from lasers penetrate deeply into tissues and accelerate cellular reproduction and growth. The laser light also increases the energy available to the cell by increasing ATP production so that the cell can take on nutrients faster and get rid of waste products. As a result of exposure to laser light, all cells, including the cells of tendons, ligaments, and muscles, are repaired faster.

Improved Vascular Activity. LLLT significantly increases the formation of new capillaries in damaged tissue, which speeds up the healing process, closes wounds more quickly, and reduces scarring. LLLT also causes vasodilation – an increase in the diameter of blood vessels – which improves the delivery of blood and healing elements to damaged tissues.

Increased Metabolic Activity. LLLT stimulates higher outputs of specific pro-healing enzymes in blood cells, along with improved oxygen and nutrient delivery.

Trigger Points and Acupuncture Points. LLLT stimulates muscle trigger points and acupuncture points on a non-invasive basis, providing musculoskeletal pain relief.

Reduced Fibrous Tissue Formation. LLLT reduces the formation of scar tissue following damage from cuts, scratches, burns, or surgery.

Improved Nerve Function. Slow recovery of nerves in damaged tissue results in impaired sensory and motor function. LLLT speeds up the process of axonal regeneration and nerve cell reconnection, and increases the amplitude of action potentials to optimize muscle action.
​
Immunoregulation. LLLT directly affects immunity status by stimulating the production of immunoglobulins and lymphocytes, and by improving the ease of penetration of white blood cells into damaged tissue.

Faster Wound Healing. LLLT stimulates fibroblast development in damaged tissue. Fibroblasts are the building blocks of collagen, which is the essential protein required to replace old tissue or repair tissue injuries. As a result, LLLT is effective on open wounds and burns.

Our Laser Device

Our Low Level Laser device is FDA 510(K) market cleared and entered in the TGA (ARTG 393431) for treating chronic / acute neck and shoulder pain, musculoskeletal pain, and acne vulgaris.
​
This dual-diode laser with red and violet wavelength allows the device to treat a wide variety of pain including: Orthopaedic pain – sprains, whiplash, muscular pain, cervical or lumbar radiculopathy, tendinitis, and carpal tunnel syndrome. The device has also shown positive effects on individuals with chronic conditions like arthritis and osteoarthritis, and in treating post-surgical pain; Neuropathic pain, including various types of neuralgia and diabetic neuropathy; Pain management for athletes recovering from training or injuries; Bacterial, fungal, or viral infections.

How does it work?
​
The Laser delivers parcels of light energy into the cell which the cell can use, and the parcels are delivered in the most effective and efficient way. This added energy fuels key processes, stimulating healing, relieving pain, reducing inflammation, and restoring function.
​
The Laser emits two true laser beams – a red laser promotes healing through its 635nm beam (7.5mW output), and a violet laser provides an antimicrobial effect through its 405nm beam (5mW output).

​Laser device  Specifications ​(download datasheet)

​​EVRL® Laser  Specifications
​(download datasheet)

Laser Therapy for Pain Relief

The Science

While the benefits of Low-Level Laser Therapy (LLLT) have been observed in hundreds of medical studies, the exact mechanisms that lead to these results are still being explored. Although we still have a lot to learn about the effects of light energy on different types of cells, the leading theory is that LLLT generates therapeutic effects through stimulating and enhancing specific biochemical processes within cells.

More specifically, utilising the first law in photochemistry (Grotthuss-Draper law), laser energy is transferred to cytochrome c oxidase (CcO) – a respiratory energy-transducing enzyme which is involved in the electron transport chain in mitochondria. This energy transfer causes photodissociation of inhibitory nitric oxide from CcO, leading to an enhancement of enzyme activity, electron transport, mitochondrial respiration, and adenosine triphosphate (ATP) production. Consequently, by altering the cellular redox state, LLLT induces the activation of numerous intracellular signalling pathways, and alters the affinity of transcription factors concerned with cell proliferation, survival, repair, and regeneration.

Our lasers utilise true laser technology, optimising photonic energy delivery through the use of monochromatic, collimated, and coherent beams of light. That is, the light emitted by a true laser is composed from photons that have the same wavelength (monochromatic), travel in the same direction / do not disperse (collimated), and are in phase in space and time (coherent). 
​
These lasers were specifically designed to deliver the optimal amount of energy required to stimulate and enhance cell function while not damaging cells or producing painful heat sensations – all of our non-thermal LLLT devices are classified as ‘Class II Lasers’ by the FDA in virtue of their low output and very low risk of hazard.

The benefits of Low Level Laser

Clinical studies and trials of Laser Therapy technologies indicate the following beneficial effects of Low-Level Laser Therapy (LLLT).

Anti-Inflammation. LLLT creates an anti-edema effect by dilating blood vessels and activating the lymphatic drainage system (which drains swollen areas). This reduces swelling caused by trauma or inflammation.
​
Anti-Pain (Analgesic). LLLT exerts a very beneficial effect on pain in multiple ways: It partially blocks neural transmission of pain signals to the brain; It decreases nerve sensitivity; It lessens pain by reducing edema; It helps to increase the production of high levels of painkilling chemicals such as endorphins, enkephalins, and opioids from the brain and adrenal gland.

Accelerated Tissue Repair and Cell Growth. Photons of light from lasers penetrate deeply into tissues and accelerate cellular reproduction and growth. The laser light also increases the energy available to the cell by increasing ATP production so that the cell can take on nutrients faster and get rid of waste products. As a result of exposure to laser light, all cells, including the cells of tendons, ligaments, and muscles, are repaired faster.

Improved Vascular Activity. LLLT significantly increases the formation of new capillaries in damaged tissue, which speeds up the healing process, closes wounds more quickly, and reduces scarring. LLLT also causes vasodilation – an increase in the diameter of blood vessels – which improves the delivery of blood and healing elements to damaged tissues.

Increased Metabolic Activity. LLLT stimulates higher outputs of specific pro-healing enzymes in blood cells, along with improved oxygen and nutrient delivery.

Trigger Points and Acupuncture Points. LLLT stimulates muscle trigger points and acupuncture points on a non-invasive basis, providing musculoskeletal pain relief.

Reduced Fibrous Tissue Formation. LLLT reduces the formation of scar tissue following damage from cuts, scratches, burns, or surgery.

Improved Nerve Function. Slow recovery of nerves in damaged tissue results in impaired sensory and motor function. LLLT speeds up the process of axonal regeneration and nerve cell reconnection, and increases the amplitude of action potentials to optimize muscle action.
​
Immunoregulation. LLLT directly affects immunity status by stimulating the production of immunoglobulins and lymphocytes, and by improving the ease of penetration of white blood cells into damaged tissue.

Faster Wound Healing. LLLT stimulates fibroblast development in damaged tissue. Fibroblasts are the building blocks of collagen, which is the essential protein required to replace old tissue or repair tissue injuries. As a result, LLLT is effective on open wounds and burns.

Frequently Asked Questions

FAQ's

How does laser therapy work?

Low-Level Laser Therapy works by sending concentrated beams of light energy directly into cells, providing them with extra energy to enhance crucial processes. This boost in energy facilitates healing, alleviates pain, lessens inflammation, and restores normal function. The therapy employs two true laser beams: a red laser (635nm, 7.5mW output) promotes healing, and a violet laser (405nm, 5mW output) has an antimicrobial effect.

What are the benefits?

Low-Level Laser Therapy (LLLT) boasts proven health benefits through clinical studies. It reduces inflammation, eases swelling by expanding blood vessels, and activating lymphatic drainage. LLLT acts as a pain reliever by blocking pain signals and reducing nerve sensitivity. Utilising light photons, it accelerates tissue repair, enhances cellular reproduction, and nutrient exchange. Increased vascular activity fosters new capillary formation, expediting healing and minimizing scarring. LLLT heightens metabolic activity, triggering pro-healing enzymes, and improving oxygen delivery. It aids in musculoskeletal pain relief, curtails fibrous tissue formation, enhances nerve function, supports swifter wound healing, and promotes overall well-being through immunoregulation.

What can laser help with?

Low-Level Laser Therapy (LLLT) aids in various orthopedic issues, including sprains, whiplash, muscle pain, and conditions like cervical or lumbar radiculopathy, tendinitis, and carpal tunnel syndrome. It demonstrates positive effects in managing chronic conditions such as arthritis and osteoarthritis, and eases post-surgical pain. LLLT is beneficial for neuropathic pain, addressing neuralgia and diabetic neuropathy. Athletes in recovery can find relief through LLLT for pain management. Additionally, it shows promise in dealing with bacterial, fungal, or viral infections, showcasing its versatility in supporting overall well-being.

Who cannot use laser therapy?

There are no officially specified restrictions based on medical codes, but we advise against using Low-Level Laser Therapy on pregnant women, individuals with a pacemaker, or those with photosensitive epilepsy due to the lack of long-term evaluations on these specific conditions. Additionally, it's not recommended to use the device over an area where cancer is already known to be present.

Will laser therapy cause pain?

No. Low Level Laser Therapy is a true Non-Thermal Low-Level Laser and causes no pain or health risks.

How long is a treatment?

The Low Level Laser Therapy treatment sessions are up to 30 minutes long and are relaxing to administer.

Clinical Studies

All studies carried out to obtain FDA-clearance are double blind, randomised, placebo-controlled, and multi-site – the most credible research in the market.

The following list shows the clinical trials and an outline of their progress. As a company, to protect our intellectual assets, not all clinical trials we are involved with are made public so as to maintain our competitive advantage. As such, not all clinical trials are listed below.

Please note: EVRL® is new in series – several clinical studies were performed on its predecessors (with the same mechanisms of action).

Please also note: There are hundreds of clinical studies confirming the effectiveness of Low-Level Laser Therapy (LLLT), and every year there are many new publications. Below is a list of Erchonia-specific studies for FDA-clearance.

1) Market Clearance for Relief of Chronic Musculoskeletal Pain (FX 635) — 2019 — A collection of placebo-controlled, randomized, double-blind, parallel-group, multi-center clinical studies. FDA-clearance – K190572

2) Market Clearance to Treat Chronic Low Back Pain (FX 635) — 2018 — Placebo-controlled, randomized, double-blind, parallel-group, multi-center clinical study. FDA-clearance – K180197. To view NIH clinical trial records, click here.

3) Erchonia EVRL (EVRL) – 2016

​a. while using the red diode, for adjunctive use in providing temporary relief of minor chronic neck and shoulder pain of musculoskeletal origin.

​b. and while using the violet diode, to treat dermatological conditions, and specifically indicated to treat moderate inflammatory Acne Vulgaris. FDA-clearance – K152196

4) Adjunct to Chronic Heel Pain Arising from Plantar Fasciitis Using the Erchonia FX635 Laser — 2012 — Sponsor and Monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study. FDA-clearance – K132940

Study results published in the American Orthopaedic Foot & Ankle Society April 2014. To view NIH clinical trial records, click here.

5) Equine Wound Healing – 2011 — Sponsor, placebo controlled, clinical study. Study completed from Feb. 2011-April 2011. Monitored by Hank Jann, DVM, MS, DAVCS from Oklahoma State University.

6) Equine Wound Healing – 2011 — Sponsor, Case Study. Study completed from Nov. 2010-March 2011. Monitored by Hank Jann, DVM, MS, DACVS from Oklahoma State University.

7) Pain Associated With Breast Augmentation Surgery / Low-Level Laser — 2007 — Sponsor and Monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study. Results used to obtain FDA-clearance – K072206. To view NIH clinical trial records, click here.

8) Acne Vulgaris — Dermatological Conditions / Low-Level Laser — 2005 — Sponsor and Monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study. FDA-clearance – K050672

9) Low-Level Laser Light Therapy as an Aid to Liposuction and Reduction of Pain Associated With Surgery — 2004 — Sponsor and Monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study. Study results used to obtain FDA-clearance – K041139. To view NIH clinical trial records, click here.

10) Chronic Neck and Shoulder Pain / Low-Level Laser — 2001 — Sponsor and Monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study. Study results used to obtain FDA-clearance – K012580. To view NIH clinical trial records, click here.

11) Chronic Neck and Shoulder Pain / Low-Level Laser — 2000 — Sponsor and Monitor, IRB approved, double blind, placebo controlled, multi-site, clinical study.
​
First study done in support of 510(k) submission, second study requested by FDA.